Mimedx (MDXG) Change in Receivables (2011 - 2026)

Mimedx has disclosed Change in Receivables across 15 years of filings, most recently posting -$28.2 million for Q1 2026.

• Change in Receivables for Q1 2026 came in at -$28.2 million, down 491.63% year-over-year; the trailing twelve-month figure through Mar 2026 was -$9.0 million (down 240.66% YoY), and the FY2025 annual result was $26.4 million, up 934.25% from the prior year.
• Change in Receivables came in at -$28.2 million for Q1 2026 at Mimedx, down from $887000.0 in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $11.0 million in Q3 2025 to a low of -$28.2 million in Q1 2026.
• The 5-year median for Change in Receivables is $2.4 million (2022), against an average of $1.1 million.
• Across the five-year window, Change in Receivables slumped 89200.0% in 2022 and jumped 1055.72% in 2025, its largest moves.
• Mimedx's Change in Receivables stood at $2.6 million in 2022, then surged by 111.13% to $5.6 million in 2023, then tumbled by 59.61% to $2.3 million in 2024, then sank by 60.63% to $887000.0 in 2025, then tumbled by 3280.27% to -$28.2 million in 2026.
• The last three Change in Receivables figures came in at -$28.2 million (Q1 2026), $887000.0 (Q4 2025), and $11.0 million (Q3 2025), per Business Quant data.